This trial is active, not recruiting.

Condition pulmonary fungal diseases
Sponsor University Hospital, Gasthuisberg
Start date October 2013
End date April 2014
Trial size 100 participants
Trial identifier NCT01958710, ASPERLEU


Retrospective analysis of surgery and/or bronchial embolisation for pulmonary aspergilloma.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective retrospective
(preoperative) embolisation of the bronchial circulation
Any surgically treated patient with a functional lung resection (at least wedge resection)

Primary Outcomes

survival after treatment
time frame: 10 years

Secondary Outcomes

post treatment survival
time frame: 90 days

Eligibility Criteria

Male or female participants from 1 year up to 89 years old.

Inclusion Criteria: - Histological proven Aspergilloma of the lung Exclusion Criteria: - Treatment limited to the use of systemic antifungal agents

Additional Information

Official title Outcome After Surgical Treatment or Bronchial Embolisation in Aspergilloma of the Lung: a Single Center Experience.
Principal investigator Herbert Decaluwé, MD
Description A retrospective chart analysis, based on the search results from a thoracic surgery database and an interventional radiology database. Outcome analysis of all surgically treated patients for a confirmed invasive aspergilloma. Comparisson with (preoperative) embolisation of the bronchial circulation.
Trial information was received from ClinicalTrials.gov and was last updated in October 2013.
Information provided to ClinicalTrials.gov by University Hospital, Gasthuisberg.